FIELD: medicine, pharmacy, biotechnology. SUBSTANCE: invention relates to stabilization of "lipid : DNA" in the process of spraying. Invention involves pharmaceutical compound including plasmid DNA carrying gene, cationic lipid, neutral lipid and trypton or glutamic acid and spraying suspension including cationic lipid bis-(guanidinium)-trencholesterol, neutral colipid dioleoylphosphatidylethanolamine or its analogue and plasmid DNA carrying gene also. Invention provides the development of medicinal form used in gene therapy. EFFECT: improved stability, valuable properties of composition. 11 cl, 5 dwg
Authors
Dates
2003-10-10—Published
1999-01-08—Filed